Search - tctmd.com

Displaying 241 - 260 of 260

Sort: Relevancy | Date

News Conference News ACC 2012

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

L.A. McKeown

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Conference News ACC 2012

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Jason Kahn

March 24, 2012

Presentation TCT 2012

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Ke Xu, Avery E. Clark, Rebecca Pinnelas, Bernhard Witzenbichler, Ran Kornowski, Giulio Gaugliumi, Eugenia Nikolsky, Bruce R. Brodie, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Presenter: Jennifer Yu, Roxana Mehran, Liliana Grinfeld, Ke Xu, Martin Fahy, Eugenia Nikolsky, Rebecca Pinnelas, Avery E. Clark, Bruce R. Brodie, Martin Mockel, Bernard Witzenbichler, Ran Kornowski, Dariusz Dudek, Alexandra J. Lansky, George Dangas, Gregg W. Stone

January 03, 2012

$Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...$

Presentation TCT 2012

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Presenter: Shyam Poludasu, Usman Baber, Chabbra Sandeep, Jennifer Yu, Rebecca Pinnelas, Avery E. Clark, Roxana Mehran, George Dangas, Annapoorna S. Kini, Samin K. Sharma

January 03, 2012

Presentation TCT 2012

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Presenter: Eugenia Nikolsky, Bernard J. Gersh, Dangas D. George, Shing-Chiu Wong, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W. Stone

January 03, 2012

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Conference News

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

November 07, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

Video

» Conference Wrap-Up

ESC 2025 Wrap-up

August 31, 2025

Video

» Interview

Advertisement

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Predictors of Major Adverse Events in Female Patients with Acute Myocardial Infarction undergoing Primary PCI: Three Year Results from the HORIZONS-AMI Study

Outcomes of Women after Acute Myocardial Infarction: Results from the HORIZONS-AMI Study

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

IVUS Guidance of DES Implantation Improves Outcomes

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Study Examines Predictors of Thrombus Aspiration Failure in Primary PCI

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

ESC 2025 Wrap-up

On Record: Out With ABIM, In With a CV Board

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content